Tower Cancer Research Foundation

Site:	Tower Cancer Research Foundation	Go to their website
Address:	9090 Wilshire Blvd Suite 350
City:	Beverly Hills
State:	CA
Zip:	90211
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
2	MEK Inhibitor AZD6244 With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery	Ongoing, but not recruiting	Closed	AZD6244 plus Temsirolimus	NCT01206140
1	Perifosine + Sunitinib Malate for Patients With Advanced Cancers	Completed	Closed	Perifosine + Sunitinib	NCT00399152